Journal article

Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer-Response

Christopher M Hovens, Matthew KH Hong, Niall M Corcoran

Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2014

DOI: 10.1158/1078-0432.CCR-14-1536

University of Melbourne Researchers

Christopher Hovens Author Surgery - Royal Melbourne Hospital

Niall Corcoran Author Surgery - Royal Melbourne Hospital

Keywords

Drug Resistance, Neoplasm

Life Sciences & Biomedicine

Science & Technology

Prostatic Neoplasms

Androstenedione